We are live on ! Find out more
SP

Sarasin & Partners Portfolio holdings

AUM $8.54B
1-Year Est. Return 9.6%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+9.6%
3 Year Est. Return
+77.95%
5 Year Est. Return
+86.04%
10 Year Est. Return
+393.05%
AUM
$6.38B
AUM Growth
+$353M
Cap. Flow
+$107M
Cap. Flow %
1.68%
Top 10 Hldgs %
33.89%
Holding
143
New
7
Increased
47
Reduced
56
Closed
13

Top Buys

Rank Stock Value
1
COR icon
Cencora
COR
+$104M
2
TSM icon
TSMC
TSM
+$63.3M
3
AMT icon
American Tower
AMT
+$42.1M
4
FRC
First Republic Bank
FRC
+$40.2M
5
WFC icon
Wells Fargo
WFC
+$38.9M

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$73.3M
2
LNKD
LinkedIn Corporation
LNKD
+$44.7M
3
EMR icon
Emerson Electric
EMR
+$31.6M
4
LMT icon
Lockheed Martin
LMT
+$27.3M
5
GE icon
GE Aerospace
GE
+$26.2M

Sector Composition

Rank Sector Weight
1 Financials 15.87%
2 Consumer Discretionary 14.03%
3 Communication Services 10.18%
4 Industrials 9.48%
5 Consumer Staples 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HON icon
101
Honeywell
HON
$77B
$2.88M 0.05%
27,442
FXI icon
102
iShares China Large-Cap ETF
FXI
$4.35B
$2.84M 0.04%
74,776
TCO
103
DELISTED
Taubman Centers Inc.
TCO
$2.78M 0.04%
37,320
+925
+3% +$71.4K
FLOT icon
104
iShares Floating Rate Bond ETF
FLOT
$10.2B
$2.54M 0.04%
50,000
BG icon
105
Bunge Global
BG
$20.2B
$2.24M 0.04%
37,780
SIVB
106
DELISTED
SVB Financial Group
SIVB
$2.17M 0.03%
19,591
BWA icon
107
BorgWarner
BWA
$13B
$2.13M 0.03%
68,669
-297,270
-81% -$8.76M
DOC icon
108
Healthpeak Properties
DOC
$15.1B
$1.97M 0.03%
56,925
-306
-0.5% -$10.7K
IBA
109
DELISTED
Industrias Bachoco SAB De C.V.
IBA
$1.86M 0.03%
37,000
IP icon
110
International Paper
IP
$21.9B
$1.85M 0.03%
40,645
-3,772
-8% -$166K
DEI icon
111
Douglas Emmett
DEI
$1.99B
$1.83M 0.03%
49,947
+477
+1% +$17.6K
BRFS
112
DELISTED
BRF SA
BRFS
$1.66M 0.03%
97,144
-1,556
-2% -$25.3K
VT icon
113
Vanguard Total World Stock ETF
VT
$76.8B
$1.46M 0.02%
24,000
KBE icon
114
State Street SPDR S&P Bank ETF
KBE
$1.64B
$1.4M 0.02%
41,813
SRCL
115
DELISTED
Stericycle Inc
SRCL
$1.4M 0.02%
17,412
GE icon
116
GE Aerospace
GE
$373B
$1.15M 0.02%
8,097
-175,806
-96% -$26.2M
HDB icon
117
HDFC Bank
HDB
$123B
$925K 0.01%
51,468
-256
-0.5% -$4.5K
DHC
118
Diversified Healthcare Trust
DHC
$2.17B
$919K 0.01%
40,470
TAL icon
119
TAL Education Group
TAL
$6.92B
$906K 0.01%
76,704
-396
-0.5% -$4.18K
VZ icon
120
Verizon
VZ
$194B
$757K 0.01%
14,556
+409
+3% +$22K
MWA icon
121
Mueller Water Products
MWA
$3.96B
$681K 0.01%
54,287
-31,708
-37% -$380K
BN icon
122
Brookfield
BN
$105B
$633K 0.01%
50,449
NBIS
123
Nebius Group N.V.
NBIS
$46.9B
$601K 0.01%
28,555
-3,345
-10% -$72.8K
MSFT icon
124
Microsoft
MSFT
$3.43T
$595K 0.01%
10,336
-1,134
-10% -$64K
PGF icon
125
Invesco Financial Preferred ETF
PGF
$675M
$572K 0.01%
+30,000
New +$578K

Similar funds

Sarasin & Partners's Q3 2016 Portfolio in Review

As of Q3 2016, Sarasin & Partners held 143 positions worth $6.38B, up 5.9% from $6.02B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Sarasin & Partners's Q3 2016 filing shows 7 new, 47 increased, 56 reduced and 13 closed positions. Its largest new stake was Cencora: 1,208,708 shares worth $97.6M. The largest sale was Citigroup, an estimated $73.3M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Sarasin & Partners's largest Q3 2016 buy was Cencora: 1,208,708 shares worth $97.6M.
  • Sarasin & Partners added most to TSMC in Q3 2016, an estimated $63.3M increase.
  • Sarasin & Partners's biggest Q3 2016 reduction was Citigroup, cutting an estimated $73.3M.
  • Sarasin & Partners fully exited LinkedIn Corporation in Q3 2016, selling an estimated $44.7M.
  • Sarasin & Partners's ten largest holdings make up 34% of its $6.38B portfolio in Q3 2016.
  • Sarasin & Partners opened 7 new positions and closed 13 in Q3 2016.
  • Sarasin & Partners's portfolio value rose 5.9% quarter-over-quarter to $6.38B.

Based on Sarasin & Partners's 13F filing for Q3 2016, filed 14 Oct 2016.